These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8376622)

  • 1. Modern tricyclic antidepressant drugs are hardly distinguishable in efficacy or safety for treatment of depressive mood disorders in controlled clinical trials.
    Glassman AH; Davis JM
    J Clin Psychopharmacol; 1993 Aug; 13(4):296-9. PubMed ID: 8376622
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma concentrations of tricyclic antidepressants in clinical practice.
    J Clin Psychiatry; 1982 Sep; 43(9):389-90. PubMed ID: 7118847
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma concentrations of tricyclic antidepressants in clinical practice.
    Hollister LE
    J Clin Psychiatry; 1982 Feb; 43(2):66-9. PubMed ID: 7056706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tricyclic antidepressants: clinical use of plasma levels.
    Preskorn SH; Madakasira S
    J Kans Med Soc; 1981 Mar; 82(3):122-4, 134. PubMed ID: 7276685
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of plasma concentrations in the use of tricyclic antidepressant drugs.
    Levine RR
    Prog Neuropsychopharmacol; 1979; 3(1-3):211-22. PubMed ID: 401340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined MAOI-tricylic antidepressant treatment: a controlled trial.
    White K; Razani J; Simpson G; Rebal R; Sloane RB; O'Leary J; Palmer R
    Psychopharmacol Bull; 1982 Oct; 18(4):180-1. PubMed ID: 6760234
    [No Abstract]   [Full Text] [Related]  

  • 7. Nortriptyline pharmacokinetics and plasma levels: implications for clinical practice.
    Rubin EH; Biggs JT; Preskorn SH
    J Clin Psychiatry; 1985 Oct; 46(10):418-24. PubMed ID: 3900052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma level monitoring of antidepressants: theoretical basis and clinical application.
    Gram LF; Kragh-Sørensen P; Kristensen CB; Møller M; Pedersen OL; Thayssen P
    Adv Biochem Psychopharmacol; 1984; 39():399-411. PubMed ID: 6380231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tricyclic antidepressant plasma levels: the state of the art and clinical prospects.
    Razavi D; Mendlewicz J
    Neuropsychobiology; 1982; 8(2):73-85. PubMed ID: 7070646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of therapeutic drug monitoring of amitriptyline and genotyping on efficacy and safety of depression therapy].
    Ostapowicz A; Zejmo M; Wrześniewska J; Białecka M; Górnik W; Gawrońska-Szklarz B
    Psychiatr Pol; 2000; 34(4):595-605. PubMed ID: 11059259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating depression in alcoholics.
    Douglas MB; Fleming MF
    J Fam Pract; 1996 Jun; 42(6):565-6. PubMed ID: 8656162
    [No Abstract]   [Full Text] [Related]  

  • 12. Tricyclic antidepressants--blood level measurements and clinical outcome: an APA Task Force report. Task Force on the Use of Laboratory Tests in Psychiatry.
    Am J Psychiatry; 1985 Feb; 142(2):155-62. PubMed ID: 3881999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fluoxetine and tricyclic antidepressants: clinical tolerance in short-term combined administration].
    Bonin B; Bertschy G; Baumann P; Francois T; Vandel P; Vandel S; Sechter D; Bizouard P
    Encephale; 1996; 22(3):221-7. PubMed ID: 8767051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of paroxetine in elderly patients.
    Geriatrics; 1993 Nov; 48 Suppl 2():13-5. PubMed ID: 8244039
    [No Abstract]   [Full Text] [Related]  

  • 15. Protocols for the use of psychoactive drugs - Part II: protocol for the treatment of depression with tricyclic antidepressants.
    Coleman JH; Johnston JA; Callaway JT; May CN; Druff JH
    J Clin Psychiatry; 1981 Feb; 42(2):65-8. PubMed ID: 7462172
    [No Abstract]   [Full Text] [Related]  

  • 16. Atypical depression, atypical temperament and a differential antidepressant response to fluoxetine and nortriptyline.
    Joyce PR; Mulder RT; McKenzie JM; Luty SE; Cloninger CR
    Depress Anxiety; 2004; 19(3):180-6. PubMed ID: 15129420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of fluoxetine as an antidepressant in the short and long term.
    Montgomery SA
    Int Clin Psychopharmacol; 1989 Jan; 4 Suppl 1():113-9. PubMed ID: 2644336
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacological treatment of delusional depression].
    Amore M; Giordani L; Giorgetti G; Zazzeri N
    Minerva Psichiatr; 1996 Mar; 37(1):29-33. PubMed ID: 8804200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New trends in the diagnosis and treatment of depression.
    Taska R; Brodie HK
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):11-3. PubMed ID: 6406437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoxetine efficacy vs comparative drugs: an overview.
    Lader M
    Br J Psychiatry Suppl; 1988 Sep; (3):51-8. PubMed ID: 3074866
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.